Respiratory syncytial virus infection and the immunocompromised host.
Ogra
P L
PL
Department of Pediatrics, School of Medicine, State University of New York at Buffalo.
Patel
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D006801:Humans; D007108:Immune Tolerance; D007116:Immunization, Passive; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007223:Infant; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000209:etiology / Q000628:therapy*; D012254:Ribavirin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D012254:Ribavirin